You are here

Our science / Clinical Trials / Find a Trial / NCT01073605

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

Back to Search Print Save as PDF Bookmark Trial

NCT01073605

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Amiens, , 80030 France
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Growth Disorders, Intrauterine Growth Retardation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
3-12 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Chronological age (CA) between 3 and 10 for girls

- Chronological age between 3 and 12 for boys

- Height for CA below - 2 SD

- Birth length for CA below -2SD

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Endocrine disease except well-substituted hypothyroidism

- Sever chronic disease

- Skeletal dysplasia

- Known chromosomal aberration

- Ongoing treatment with steroids

- Known intrauterine infection

NCT01073605
Pfizer
Completed
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now